Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report

doi:10.12998/wjcc.v12.i9.1685

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2316)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

HTML

1144

Figures (1-4)

147

Sum=1343

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

169

Download

400

Sum=569

Publishing Process of This Article

Item

Count

Browse

Download

265

Sum=322

Mar 26, 2024 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Mar 26, 2024; 12(9): 1685-1690
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1685

Full Size Figure Download Figure

Figure 1 Colonoscopy on November 26, 2019. A: Continuous mucosal erosions can be seen in the junction of the descending colon and sigmoid colon with more pus attached to the surface; B: Persistent mucosal erosion is observed in the sigmoid colon, covered with more pus.

Citation: Xu X, Jiang JW, Lu BY, Li XX. Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report. World J Clin Cases 2024; 12(9): 1685-1690
URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1685.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i9.1685